Accutane Psychiatric Safety Trial Planned: Roche Prepares For Hearings
Executive Summary
Roche and FDA are in discussions about the design for a prospective study to resolve questions about a potential link between the acne drug Accutane (isotretinoin) and psychiatric side effects.
You may also be interested in...
Accutane Risk Management Program Will Be Subject Of FDA Committee
FDA plans to convene an advisory committee this winter to assess the risk management program designed to prevent birth defects associated with Roche's acne therapy Accutane (isotretinoin)
Accutane Risk Management Program Will Be Subject Of FDA Committee
FDA plans to convene an advisory committee this winter to assess the risk management program designed to prevent birth defects associated with Roche's acne therapy Accutane (isotretinoin)
Roche Accutane Prescriber Registry Added To Pregnancy Prevention Program
Accutane prescribers must register with Roche to receive "qualification stickers" under the company's updated pregnancy prevention program